Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.4K
Overview
84.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
What is the Immune System?01:38

What is the Immune System?

133.1K
Overview
133.1K
Positive, Negative, and Zero Work00:58

Positive, Negative, and Zero Work

22.3K
Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
22.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clusterin reverses epitheliopathy, reduces inflammation, and restores goblet cells and corneal nerves in a mouse model of autoimmune dry eye.

Scientific reports·2026
Same author

The Therapeutic Effects of Purified Cortrophin Gel on Experimental Autoimmune Uveitis.

Ocular immunology and inflammation·2025
Same author

Clusterin reverses epitheliopathy, reduces inflammation, and restores goblet cells and corneal nerves in a mouse model of autoimmune dry eye.

bioRxiv : the preprint server for biology·2025
Same author

Induction of Retinal Ischemia-Reperfusion Injury in a Mouse Eye Model.

Journal of visualized experiments : JoVE·2025
Same author

Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion.

Biomolecules·2024
Same author

Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies.

Frontiers in immunology·2023
Same journal

Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis.

Journal of leukocyte biology·2026
Same journal

Eosinophil Essentials: Identification and Assessment of Activity.

Journal of leukocyte biology·2026
Same journal

Immune cell landscape reveals 5 immune-related subtypes and molecular characteristics with prognostic and therapeutic implications in pan-cancer.

Journal of leukocyte biology·2026
Same journal

High-dimensional single-cell mass cytometry analysis of IL-4 treated human macrophages reveals heterogeneity and a CD206high anticolitic subset.

Journal of leukocyte biology·2026
Same journal

SHIP Blocks (MDP+LPS)-Induced Synergy in Macrophages Independent of Catalytic Activity.

Journal of leukocyte biology·2026
Same journal

CD43: Recent Advances and Emerging Functions.

Journal of leukocyte biology·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Negative regulators that mediate ocular immune privilege.

Andrew W Taylor1, Tat Fong Ng1

  • 1Boston University School of Medicine, Boston, Massachusetts, USA.

Journal of Leukocyte Biology
|February 13, 2018
PubMed
Summary
This summary is machine-generated.

The eye uses molecules like TGF-β2 and immune cells to control inflammation, maintaining vision health and immune privilege. This discovery offers new avenues for treating autoimmune diseases by harnessing these natural regulators.

Keywords:
Immunosuppressionanti-inflammatoryeyeneuropeptidesregulatory T cellssuppressor macrophagestolerance

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.8K

Related Experiment Videos

Last Updated: Feb 14, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.8K

Area of Science:

  • Ophthalmology
  • Immunology
  • Molecular Biology

Background:

  • The eye possesses unique immune privilege to protect vision.
  • Inflammation can compromise ocular health and visual function.

Purpose of the Study:

  • To identify and characterize negative regulators of inflammation in the ocular microenvironment.
  • To understand the role of these regulators in maintaining immune privilege and tolerance.
  • To explore their potential for treating ocular autoimmune diseases.

Main Methods:

  • Analysis of constitutively produced negative regulators in the eye.
  • Investigating the influence of TGF-β2, α-MSH, FasL, and PD-L1 on inflammatory pathways.
  • Assessing the impact on immune cell activation and regulation under inflammatory conditions.

Main Results:

  • Identified key molecular regulators (TGF-β2, α-MSH, FasL, PD-L1) that suppress ocular inflammation.
  • Demonstrated that these regulators prevent effector immune cell activation.
  • Showed that these molecules promote regulatory immune cells, enhancing immune tolerance.

Conclusions:

  • Ocular immune privilege involves both molecular and cellular negative regulators of inflammation.
  • These regulators are crucial for preventing and resolving ocular inflammation.
  • Harnessing these negative regulators presents a promising strategy for novel autoimmune disease therapies.